RJFSA
IBB icon

Raymond James Financial Services Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Raymond James Financial Services Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$31.5M Sell
216,543
-504
-0.2% -$72.9K 0.04% 398
2024
Q2 		$29.8M Buy
217,047
+42,822
+25% +$5.72M 0.04% 388
2024
Q1 		$23.9M Buy
174,225
+20,533
+13% +$2.8M 0.04% 445
2023
Q4 		$20.9M Buy
153,692
+12,611
+9% +$1.54M 0.03% 463
2023
Q3 		$17.3M Sell
141,081
-1,089
-0.8% -$138K 0.03% 495
2023
Q2 		$18M Buy
142,170
+16,564
+13% +$2.15M 0.03% 497
2023
Q1 		$16.2M Sell
125,606
-54,612
-30% -$7.15M 0.03% 508
2022
Q4 		$23.7M Buy
180,218
+39,148
+28% +$5.06M 0.05% 379
2022
Q3 		$16.5M Buy
141,070
+18,278
+15% +$2.27M 0.04% 442
2022
Q2 		$14.4M Sell
122,792
-19,153
-13% -$2.27M 0.03% 507
2022
Q1 		$18.5M Sell
141,945
-5,222
-4% -$680K 0.03% 473
2021
Q4 		$22.5M Buy
147,167
+13,766
+10% +$2.13M 0.04% 414
2021
Q3 		$21.6M Sell
133,401
-18,412
-12% -$3.1M 0.04% 420
2021
Q2 		$24.8M Buy
151,813
+4,962
+3% +$764K 0.05% 366
2021
Q1 		$22.1M Buy
146,851
+6,310
+4% +$1M 0.05% 366
2020
Q4 		$21.3M Sell
140,541
-26,377
-16% -$3.77M 0.05% 336
2020
Q3 		$22.6M Buy
166,918
+22,476
+16% +$3.05M 0.06% 296
2020
Q2 		$19.7M Buy
144,442
+19,904
+16% +$2.54M 0.06% 302
2020
Q1 		$13.4M Sell
124,538
-11,945
-9% -$1.38M 0.06% 301
2019
Q4 		$16.4M Sell
136,483
-4,115
-3% -$459K 0.05% 365
2019
Q3 		$14M Sell
140,598
-11,875
-8% -$1.24M 0.05% 387
2019
Q2 		$16.6M Sell
152,473
-40,378
-21% -$4.29M 0.06% 329
2019
Q1 		$21.6M Buy
192,851
+28,209
+17% +$3.09M 0.09% 248
2018
Q4 		$15.9M Sell
164,642
-7,290
-4% -$774K 0.08% 262
2018
Q3 		$21M Buy
171,932
+1,287
+0.8% +$152K 0.09% 246
2018
Q2 		$18.7M Buy
+170,645
New +$18.3M 0.1% 241
2018
Q1 		– Sell
-224,012
Closed -$23.9M – 2627
2017
Q4 		$23.9M Buy
224,012
+4,682
+2% +$500K 0.15% 156
2017
Q3 		$24.4M Buy
219,330
+28,755
+15% +$3.07M 0.16% 147
2017
Q2 		$19.7M Buy
190,575
+20,181
+12% +$1.99M 0.14% 170
2017
Q1 		$16.7M Buy
170,394
+6,924
+4% +$663K 0.13% 194
2016
Q4 		$14.5M Buy
163,470
+63,243
+63% +$5.76M 0.12% 197
2016
Q3 		$9.67M Buy
100,227
+22,077
+28% +$2.1M 0.09% 264
2016
Q2 		$6.7M Buy
78,150
+11,064
+16% +$993K 0.06% 325
2016
Q1 		$5.83M Sell
67,086
-15,828
-19% -$1.42M 0.07% 323
2015
Q4 		$9.35M Buy
82,914
+19,407
+31% +$2.11M 0.11% 233
2015
Q3 		$6.42M Buy
+63,507
New +$7.62M 0.11% 231
2014
Q2 		– Sell
-68,298
Closed -$5.38M – 516
2014
Q1 		$5.38M Sell
68,298
-3,798
-5% -$316K 0.32% 82
2013
Q4 		$5.46M Sell
72,096
-3,135
-4% -$222K 0.33% 83
2013
Q3 		$5.26M Buy
75,231
+26,577
+55% +$1.74M 0.35% 77
2013
Q2 		$2.82M Buy
+48,654
New +$2.81M 0.08% 284

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Raymond James Financial Services Advisors's IBB Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its iShares Biotechnology ETF (IBB) stake by 0.23% in Q3 2024, selling an estimated $72.9K and leaving 216,543 shares worth $31.5M. The position accounts for 0.04% of the portfolio, ranked #398.

Raymond James Financial Services Advisors first reported a position in IBB in Q2 2013 and has held it in 40 quarters since. 894 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

  • Raymond James Financial Services Advisors held 216,543 shares of iShares Biotechnology ETF worth $31.5M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 504 iShares Biotechnology ETF shares in Q3 2024, an estimated $72.9K.
  • iShares Biotechnology ETF made up 0.04% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #398 holding.
  • Raymond James Financial Services Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 40 quarters since.
  • 894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.